José‐Luis Gomez

发表

Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women

C. Labrie, P. Bélanger, R. Bérubé, 2009, Menopause.

Comparable amounts of sex steroids are made outside the gonads in men and women: Strong lesson for hormone therapy of prostate and breast cancer

D. Mellström, C. Ohlsson, L. Vandenput, 2009, The Journal of Steroid Biochemistry and Molecular Biology.

Major impact of hormonal therapy in localized prostate cancer—death can already be an exception

C. Labrie, F. Labrie, L. Cusan, 2004, The Journal of Steroid Biochemistry and Molecular Biology.

Can combined androgen blockade provide long-term control or possible cure of localized prostate cancer?

F. Labrie, L. Cusan, José‐Luis Gomez, 2002, Urology.

Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy

C. Labrie, F. Labrie, C. Martel, 2009, Menopause.

Relationship among initial serum prostate specific antigen, prostate specific antigen progression and prostate cancer detection at repeat screening visits.

F. Labrie, L. Cusan, José‐Luis Gomez, 2006, The Journal of urology.

DHEA and the Intracrine Formation of Androgens and Estrogens in Peripheral Target Tissues: Its Role during Aging

J. Simard, C. Labrie, F. Labrie, 1998, Steroids.

Lack of influence of dyspareunia on the beneficial effect of intravaginal prasterone (dehydroepiandrosterone, DHEA) on sexual dysfunction in postmenopausal women.

C. Labrie, F. Labrie, C. Martel, 2014, The journal of sexual medicine.

Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women

P. Bélanger, R. Bérubé, F. Labrie, 2006, The Journal of Steroid Biochemistry and Molecular Biology.

Effect of intravaginal DHEA on serum DHEA and eleven of its metabolites in postmenopausal women

C. Labrie, P. Bélanger, R. Bérubé, 2008, The Journal of Steroid Biochemistry and Molecular Biology.

Changes in serum DHEA and eleven of its metabolites during 12-month percutaneous administration of DHEA

R. Bérubé, F. Labrie, C. Martel, 2008, The Journal of Steroid Biochemistry and Molecular Biology.

Metabolism of DHEA in postmenopausal women following percutaneous administration

R. Bérubé, F. Labrie, C. Martel, 2007, The Journal of Steroid Biochemistry and Molecular Biology.

Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration

C. Labrie, R. Bérubé, F. Labrie, 2009, Menopause.

Combination Therapy with Flutamide: The Therapy of Choice from Early to Advanced Stages of Prostate Cancer

F. Labrie, L. Cusan, José‐Luis Gomez, 1996 .

Intravaginal prasterone (DHEA) provides local action without clinically significant changes in serum concentrations of estrogens or androgens

C. Labrie, R. Bérubé, F. Labrie, 2013, The Journal of Steroid Biochemistry and Molecular Biology.

Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women

C. Labrie, F. Labrie, C. Martel, 2009, Menopause.

647: Relationship Between the PSA Value at First Visit and PSA Progression and Prostate Cancer Diagnosis at Annual Follow-Up Visits

F. Labrie, L. Cusan, José‐Luis Gomez, 2004 .

Gonadotropin-releasing hormone agonists in the treatment of prostate cancer.

J. Simard, C. Labrie, F. Labrie, 2005, Endocrine reviews.

Down-staging of early stage prostate cancer before radical prostatectomy: The first randomized trial of neoadjuvant combination therapy with flutamide and a luteinizing hormone-releasing hormone agonist

F. Labrie, Y. Fradet, José‐Luis Gomez, 1994 .

Efficacy and Safety of Dipyrone Versus Tramadol in the Management of Pain After Hysterectomy: A Randomized, Double-Blind, Multicenter Study

José‐Luis Gomez, E. Calderón, L. Torres, 2000, Regional Anesthesia & Pain Medicine.

The impact of family history on early detection of prostate cancer

S. Narod, F. Labrie, José‐Luis Gomez, 1995, Nature Medicine.

Screening decreases prostate cancer mortality: 11‐year follow‐up of the 1988 Quebec prospective randomized controlled trial

F. Labrie, José‐Luis Gomez, A. Bélanger, 2004, The Prostate.

Metastatic prostate cancer pulmonary nodules: Beneficial effects of combination therapy and subsequent withdrawal of flutamide

F. Labrie, L. Cusan, José‐Luis Gomez, 1994, The Prostate.

Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancer

F. Labrie, José‐Luis Gomez, B. Candas, 2000, The Prostate.

Screening decreases prostate cancer death: First analysis of the 1988 Quebec Prospective Randomized Controlled Trial

F. Labrie, José‐Luis Gomez, A. Dupont, 1999, The Prostate.

High internal consistency and efficacy of intravaginal DHEA for vaginal atrophy

C. Labrie, F. Labrie, C. Martel, 2010, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Corrigendum to “Effect of intravaginal DHEA on serum DHEA and eleven of its metabolites in postmenopausal women” [Journal of Steroid Biochemistry and Molecular Biology (2008) 178–194]

C. Labrie, R. Bérubé, F. Labrie, 2008, The Journal of Steroid Biochemistry and Molecular Biology.

The Laval University Screening Trial Results

F. Labrie, José‐Luis Gomez, B. Candas, 2001 .

Screening and treatment of localized prostate cancer decreases mortality: First analysis of the first prospective and randomized study on prostate cancer screening

F. Labrie, José‐Luis Gomez, B. Candas, 1999 .